GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » American Bio Medica Corp (OTCPK:ABMC) » Definitions » Cyclically Adjusted Revenue per Share

American Bio Medica (American Bio Medica) Cyclically Adjusted Revenue per Share : $0.21 (As of Mar. 2023)


View and export this data going back to . Start your Free Trial

What is American Bio Medica Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

American Bio Medica's adjusted revenue per share for the three months ended in Mar. 2023 was $0.003. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $0.21 for the trailing ten years ended in Mar. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2024-06-08), American Bio Medica's current stock price is $0.0001. American Bio Medica's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2023 was $0.21. American Bio Medica's Cyclically Adjusted PS Ratio of today is 0.00.


American Bio Medica Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for American Bio Medica's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Bio Medica Cyclically Adjusted Revenue per Share Chart

American Bio Medica Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.36 0.32 0.28 0.25 0.22

American Bio Medica Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.25 0.24 0.23 0.22 0.21

Competitive Comparison of American Bio Medica's Cyclically Adjusted Revenue per Share

For the Diagnostics & Research subindustry, American Bio Medica's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


American Bio Medica's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, American Bio Medica's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where American Bio Medica's Cyclically Adjusted PS Ratio falls into.



American Bio Medica Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, American Bio Medica's adjusted Revenue per Share data for the three months ended in Mar. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2023 (Change)*Current CPI (Mar. 2023)
=0.003/127.3478*127.3478
=0.003

Current CPI (Mar. 2023) = 127.3478.

American Bio Medica Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201306 0.107 98.518 0.138
201309 0.102 98.790 0.131
201312 0.094 98.326 0.122
201403 0.088 99.695 0.112
201406 0.078 100.560 0.099
201409 0.075 100.428 0.095
201412 0.071 99.070 0.091
201503 0.061 99.621 0.078
201506 0.065 100.684 0.082
201509 0.061 100.392 0.077
201512 0.059 99.792 0.075
201603 0.055 100.470 0.070
201606 0.055 101.688 0.069
201609 0.052 101.861 0.065
201612 0.042 101.863 0.053
201703 0.046 102.862 0.057
201706 0.045 103.349 0.055
201709 0.046 104.136 0.056
201712 0.032 104.011 0.039
201803 0.035 105.290 0.042
201806 0.036 106.317 0.043
201809 0.029 106.507 0.035
201812 0.029 105.998 0.035
201903 0.029 107.251 0.034
201906 0.029 108.070 0.034
201909 0.027 108.329 0.032
201912 0.027 108.420 0.032
202003 0.021 108.902 0.025
202006 0.049 108.767 0.057
202009 0.025 109.815 0.029
202012 0.021 109.897 0.024
202103 0.015 111.754 0.017
202106 0.013 114.631 0.014
202109 0.014 115.734 0.015
202112 0.010 117.630 0.011
202203 0.007 121.301 0.007
202206 0.004 125.017 0.004
202209 0.004 125.227 0.004
202212 0.003 125.222 0.003
202303 0.003 127.348 0.003

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


American Bio Medica  (OTCPK:ABMC) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

American Bio Medica's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=0.0001/0.21
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


American Bio Medica Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of American Bio Medica's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


American Bio Medica (American Bio Medica) Business Description

Traded in Other Exchanges
N/A
Address
122 Smith Road, Kinderhook, New York, NY, USA, 12106
American Bio Medica Corp is a us-based company engaged in manufacturing and selling lateral flow immunoassay tests, primarily for the immediate detection of certain drugs in urine and oral fluids at the point of collection. It also manufactures and sells drug testing products and provides bulk test strip manufacturing services to unaffiliated third parties on a contract basis. The company offers few urine tests which include Rapid Drug Screen, RDS InCup, Rapid TOX, and Rapid TOX Cup II. Its target customer includes workplace, government, corrections, clinical and educational markets. Geographically, it derives a majority of revenue from the United States.
Executives
Stuart Steinberg 10 percent owner 85 BELLEVUE AVENUE, RYE NY 10580
John J Moroney 10 percent owner 118 PEGASUS DR., JUPITER FL 33477
Chaim Davis director 2601 PINE TREE DRIVE, MIAMI BEACH FL 33140
Peter Jerome director 7 RIDGECREST AVE, LATHAM NY 12110
Diane Generous director 122 SMITH ROAD, KINDERHOOK NY 12106
Melissa A Waterhouse officer: EVP, CCO, CORP SEC AMERICAN BIO MEDICA CORPORATION, 122 SMITH ROAD, KINDERHOOK NY 12106
Mp Biomedicals Llc 10 percent owner 3 HUTTON CENTRE DRIVE, SUITE 100, SANTA ANA CA 92707
Douglas Casterlin officer: Executive Vice President C/O MELISSA A. WATERHOUSE/ABMC, 122 SMITH ROAD, KINDERHOOK NY 12106
Jean Neff director C/O ABMC, 122 SMITH ROAD, KINDERHOOK NY 12106
Stefan Parker officer: Chief Financial Officer 122 SMITH ROAD, KINDERHOOK NY 12106
Carl A Florio director C/O HUDSON RIVER BANK & TRUST CO, PO BOX 76, HUDSON NY 12534
Stan Cipkowski director 300 S LAKE DR, STE 340, FISHKILL NY 12553
Anthony G Costantino director 122 SMITH ROAD, KINDERHOOK NY 12106
Edmund M Jaskiewicz director, officer: President
Richard Koskey director C/O ABMC 122 SMITH ROAD, 122 SMITH ROAD, KINDERHOOK NY 12106

American Bio Medica (American Bio Medica) Headlines

From GuruFocus

ABMC Uplists to the OTCQB Venture Market

By ACCESSWIRE ACCESSWIRE 12-02-2020

ABMC Reports First Quarter 2020 Results

By ACCESSWIRE ACCESSWIRE 08-01-2020

ABMC Reports First Quarter 2018 Results

By ACCESSWIRE AccessWire 04-12-2019

ABMC Distributes Rapid Antigen Test For Covid-19

By ACCESSWIRE ACCESSWIRE 12-14-2020

ABMC Reports Third Quarter 2021 Results

By ACCESSWIRE ACCESSWIRE 11-18-2021

ABMC Reports Second Quarter 2021 Results

By ACCESSWIRE ACCESSWIRE 08-18-2021